Durable remission after rechallenge with ipilimumab and nivolumab in metastatic Merkel cell carcinoma refractory to avelumab: Any role for sequential immunotherapy?
2020; Wiley; Volume: 48; Issue: 2 Linguagem: Inglês
10.1111/1346-8138.15621
ISSN1346-8138
AutoresKaram Khaddour, Ilana S. Rosman, Farrokh Dehdashti, George Ansstas,
Tópico(s)Antenna Design and Analysis
ResumoThe Journal of DermatologyVolume 48, Issue 2 p. e80-e81 Letter to the Editor Durable remission after rechallenge with ipilimumab and nivolumab in metastatic Merkel cell carcinoma refractory to avelumab: Any role for sequential immunotherapy? Karam Khaddour, Karam Khaddour orcid.org/0000-0001-6697-3516 Division of Medical Oncology, Department of Medicine, Washington University in St Louis, St Louis, Missouri, USASearch for more papers by this authorIlana S. Rosman, Ilana S. Rosman Division of Dermatology, Washington University in St Louis, St Louis, Missouri, USA Department of Pathology and Immunology, Washington University in St Louis, St Louis, Missouri, USASearch for more papers by this authorFarrokh Dehdashti, Farrokh Dehdashti Division of Nuclear Medicine, Department of Radiology, Washington University in St Louis, St Louis, Missouri, USASearch for more papers by this authorGeorge Ansstas, Corresponding Author George Ansstas gansstas@wustl.edu orcid.org/0000-0002-7178-8777 Division of Medical Oncology, Department of Medicine, Washington University in St Louis, St Louis, Missouri, USA Correspondence: George Ansstas, M.D., Division of Medical Oncology, Washington University in St Louis, 660 South Euclid Avenue, St Louis, MO 63110, USA. Email: gansstas@wustl.eduSearch for more papers by this author Karam Khaddour, Karam Khaddour orcid.org/0000-0001-6697-3516 Division of Medical Oncology, Department of Medicine, Washington University in St Louis, St Louis, Missouri, USASearch for more papers by this authorIlana S. Rosman, Ilana S. Rosman Division of Dermatology, Washington University in St Louis, St Louis, Missouri, USA Department of Pathology and Immunology, Washington University in St Louis, St Louis, Missouri, USASearch for more papers by this authorFarrokh Dehdashti, Farrokh Dehdashti Division of Nuclear Medicine, Department of Radiology, Washington University in St Louis, St Louis, Missouri, USASearch for more papers by this authorGeorge Ansstas, Corresponding Author George Ansstas gansstas@wustl.edu orcid.org/0000-0002-7178-8777 Division of Medical Oncology, Department of Medicine, Washington University in St Louis, St Louis, Missouri, USA Correspondence: George Ansstas, M.D., Division of Medical Oncology, Washington University in St Louis, 660 South Euclid Avenue, St Louis, MO 63110, USA. Email: gansstas@wustl.eduSearch for more papers by this author First published: 07 November 2020 https://doi.org/10.1111/1346-8138.15621Citations: 7Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume48, Issue2Special Issue: Atopic dermatitisFebruary 2021Pages e80-e81 RelatedInformation
Referência(s)